For­mer Blue­print vets take their new biotech out of stealth, with STAT3 in their sights

A new biotech go­ing af­ter STAT mu­ta­tions through a pre­vi­ous­ly un­drug­gable tar­get emerged from stealth and se­cured its first fundraise Mon­day, in­tro­duc­ing its fresh­ly mint­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER